HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pramila Ramani Selected Research

Biological Factors

1/2015High phosphohistone H3 expression correlates with adverse clinical, biological, and pathological factors in neuroblastomas.
10/2012Carbonic anhydrase IX up-regulation is associated with adverse clinicopathologic and biologic factors in neuroblastomas.
9/2012HIF-1α up-regulation is associated with adverse clinicopathological and biological factors in neuroblastomas.
6/2012Podoplanin lymphatic density and invasion correlate with adverse clinicopathologic and biological factors and survival in neuroblastomas.
5/2012Angiogenin up-regulation correlates with adverse clinicopathological and biological factors, increased microvascular density and poor patient outcome in neuroblastomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pramila Ramani Research Topics

Disease

10Neuroblastoma
10/2015 - 10/2010
9Neoplasms (Cancer)
09/2015 - 08/2003
5Hypoxia (Hypoxemia)
04/2013 - 09/2011
3Ganglioneuroma
12/2012 - 10/2010
2Lymphatic Metastasis
12/2012 - 06/2012
1Crohn Disease (Crohn's Disease)
01/2018
1Ulcerative Colitis
01/2018
1Disease Progression
09/2015
1Colorectal Neoplasms (Colorectal Cancer)
11/2012
1Ganglion Cysts (Ganglion)
10/2012
1Hemangioma (Angioma)
11/2008
1Colitis
01/2006
1Confusion (Bewilderment)
07/2004
1Carcinoma (Carcinomatosis)
07/2004
1Leiomyosarcoma
07/2004
1Carcinogenesis
08/2003

Drug/Important Bio-Agent (IBA)

6Biological ProductsIBA
10/2015 - 05/2012
5Biological FactorsIBA
01/2015 - 05/2012
4Biomarkers (Surrogate Marker)IBA
09/2015 - 05/2012
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2013 - 10/2010
3Proteins (Proteins, Gene)FDA Link
10/2012 - 11/2008
2angiogeninIBA
04/2013 - 05/2012
2Protein Isoforms (Isoforms)IBA
11/2012 - 10/2010
2ImmunosorbentsIBA
10/2012 - 09/2011
2EnzymesIBA
10/2012 - 09/2011
1Polo-Like Kinase 1IBA
10/2015
1Translationally-Controlled 1 Tumor ProteinIBA
10/2015
1GemininIBA
09/2015
1Aurora Kinase BIBA
09/2015
1AntibodiesIBA
02/2015
1Indicators and Reagents (Reagents)IBA
02/2015
1Aurora Kinase AIBA
02/2015
1Basic Helix-Loop-Helix Transcription FactorsIBA
04/2013
1Lactate Dehydrogenase 5IBA
04/2013
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
04/2013
1Glucose Transporter Type 1IBA
02/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2012
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
12/2012
1Vascular Endothelial Growth Factor CIBA
12/2012
1Vascular Endothelial Growth Factor DIBA
12/2012
1Bevacizumab (Avastin)FDA Link
11/2012
1Carbonic Anhydrase IXIBA
10/2012
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
09/2011
1Glucose (Dextrose)FDA LinkGeneric
11/2008
1Epidermal Growth Factor (EGF)IBA
01/2006
1DesminIBA
07/2004
1Keratins (Keratin)IBA
07/2004
1Transcription Factors (Transcription Factor)IBA
08/2003
1RNA-Binding Proteins (RNA-Binding Protein)IBA
08/2003

Therapy/Procedure

1Colectomy
01/2018
1Drug Therapy (Chemotherapy)
11/2012
1Oral Administration
01/2006